Oncologists aim to fast-track personalised cancer therapy

June 26, 2014

Cancer is incredibly complex, and each tumour is unique. This calls for a targeted approach. Researchers at KU Leuven's Department of Oncology, in Belgium, want to fight cancer by developing 'personalised' cancer therapies. To bolster their efforts, they have established the new Fund for Innovative Cancer Research.

Professor Frédéric Amant is chair of the fund: "Despite the progress made in fighting cancer in recent years, we are all too often powerless. That is the reality. But it should not deter us. Our goal in establishing this fund is to finance projects that transcend the domains of oncology and have the potential to produce real breakthroughs."

The fund is now seeking financial support for the Tumour Xenograft Project, its first major fundraising target. The project is dedicated to a promising line of that significantly narrows the gap between success in the lab and success in the patient.

The 'Patient-Derived Tumour Xenograft Model' is a technique for gaining more and better information about a tumour. Professor Frédéric Amant: "The Tumour Xenograft Model is a patient-specific approach. By implanting cancerous from the patient into mice, we can study the tumour and gain insight into its structure and development, just as if it were growing in the patient."

The researchers comb through the tumour's genetic and other characteristics looking for 'biomarkers' that can be targeted by both experimental and proven therapies.

These therapies are then tested on mice carrying the tumour. If a therapy shows promising results in the mice, there is a good chance it will also be effective in the patient.

Treatments found to work for one patient can also be used to provide targeted care for other with tumours exhibiting the same biomarker.

The researchers want to use the promising 'Tumour Xenograft Model' to study as many tumour types as possible. Insights gained can be used to develop personalised therapies that give each patient the best possible chance of beating their tumour while also minimising side effects.

Because some types are extremely rare, international cooperation is essential. Tissue samples gathered during the project will be included in an international bio-bank and made available to oncologists around the world.

There are no new therapies without innovative research. In establishing this fund, the Leuven researchers call on the support and involvement of the pharmaceutical and technology industries, government and members of the public.

Explore further: 'Liquid biopsy' offers new way to track lung cancer

Related Stories

'Liquid biopsy' offers new way to track lung cancer

June 3, 2014
(Medical Xpress)—Scientists have shown how a lung cancer patient's blood sample could be used to monitor and predict their response to treatment – paving the way for personalised medicine for the disease.

Team presents a new strategy to personalise cancer therapies

April 29, 2014
Tumour cells can accumulate hundreds or even thousands of DNA mutations which induce the growth and spread of cancer. The number and pattern of mutations differs according to the type of tumour, even among those that are ...

Researchers use new simple cost effective technology to unravel cancer through standard imaging

June 3, 2014
Researchers at Maastricht University Medical Center+ (Maastricht UMC+) and the MAASTRO Clinic have developed a new medical imaging analysis method to predict the risk of dying of cancer in patients. For the first time, they ...

Now we know why drugs don't work on pancreatic cancer

June 25, 2014
The trouble with treating cancer is that each type has its own quirks. The quirks of pancreatic cancer make it one of the most lethal. The survival period after diagnosis is only four to six months. The main reason is that ...

Research discovers non–toxic cancer treatment

January 23, 2014
(Medical Xpress)—A University of Queensland researcher is developing a "Trojan horse" non-toxic treatment for human breast cancer.

Scientists identify cancer specific cell for potential targeted treatment of gastric cancer

April 23, 2014
New research by the Cancer Science Institute of Singapore and National University Hospital Singapore suggests that a variant of a cell surface protein is an ideal target for developing drugs to treat gastric cancer

Recommended for you

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.